AVE
Click for more information
25.0% 0.3¢ avecho biotechnology limited

In my view the Achillies heel for Mylan in this arbitration...

  1. kens
    2,784 Posts.
    lightbulb Created with Sketch. 497
    clock Created with Sketch.
    15/11/17
    08:51
    Post #: 28797902
    In my view the Achillies heel for Mylan in this arbitration matter has always been the original filing of a an improved daptomycin patent by Agila 3 or4 years ago.It also worth also worth noting that this patent represents another validation of TPM technology.That gives 3 independent technology validations from the likes of Novartis,Agila /Strides and Terumo.
    Kens
    POH Price at posting: 1.6¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢ 		Change
0.001(25.0%) 		Mkt cap ! $7.923M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $18 7K

Buyers (Bids)

No. Vol. Price($)
65 103358077 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 23045581 11
View Market Depth
Last trade - 11.22am 02/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.